A virus with a mutation in the ICP4-binding site in the L/ST promoter of herpes simplex virus type 1, but not a virus with a mutation in open reading frame P, exhibits cell-type-specific expression of γ134.5 transcripts and latency-associated transcripts

Journal of Virology

Volumn 72, Issue 5, 1998, Pages 4250-4264

  Lee, Lily Yeh ^a   Schaffer, Priscilla A ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CIS ACTING ELEMENT; VIRULENCE FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; INOCULATION; MOUSE; NEUROBLASTOMA CELL; NONHUMAN; NUCLEIC ACID BASE SUBSTITUTION; OPEN READING FRAME; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN SYNTHESIS; TRANSCRIPTION INITIATION; VERO CELL; VIRUS ATTENUATION; VIRUS LATENCY; VIRUS MUTANT; VIRUS MUTATION; VIRUS VIRULENCE;

EID: 2642671979     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.72.5.4250-4264.1998     Document Type: Article

References (50)

1. Ackermann, M., D. K. Braun, L. Pereira, and B. Roizman. 1984. Characterization of herpes simplex virus 1 α proteins 0, 4, and 27 with monoclonal antibodies. J. Virol. 52:108-119.
2. Ackermann, M., J. Chou, M. Sarmiento, R. A. Lerner, and B. Roizman. 1986. Identification by antibody to a synthetic peptide of a protein specified by a diploid gene located in the terminal repeats of the L component of the herpes simplex virus genome. J. Virol. 58:843-850.
3. Andrews, N. C., and D. V. Faller. 1991. A rapid micropreparation technique for extraction of DNA-binding proteins from limiting numbers of mammalian cells. Nucleic Acids Res. 19:2499.
4. Ausubel, F. M., R. Brent, R. E. Kingston, D. D. Moore, J. G. Seidman, J. A. Smith, and K. Struhl (ed.). 1988. Current protocols in molecular biology. John Wiley & Sons, Inc., New York, N.Y.
5. Bohenzky, R. A., A. G. Papavassiliou, I. H. Gelman, and S. Silverstein. 1993. Identification of a promoter mapping within the reiterated sequences that flank the herpes simplex virus type 1 UL region. J. Virol. 67:632-642.
6. Bolovan, C. A., N. A. Sawtell, and R. L. Thompson. 1994. ICP34.5 mutants of herpes simplex virus type 1 strain 17syn+ are attenuated for neurovirulence in mice and for replication in confluent primary mouse embryo cell cultures. J. Virol. 68:48-55.
7. Brown, S. M., J. Harland, A. R. MacLean, J. Podlech, and J. B. Clements. 1994. Cell type and cell state determine differential in vitro growth of non-neurovirulent ICP34.5-negative herpes simplex virus types 1 and 2. J. Gen. Virol. 75:2367-2377.
8. Bruni, R., and B. Roizman. 1996. Open reading frame P - a herpes simplex virus gene repressed during productive infection encodes a protein that binds a splicing factor and reduces synthesis of viral proteins made from spliced mRNA. Proc. Natl. Acad. Sci. USA 93:10423-10427.
9. Cai, W., and P. A. Schaffer. 1989. Herpes simplex virus type 1 ICP0 plays a critical role in the de novo synthesis of infectious virus following transfection of viral DNA. J. Virol. 63:4579-4589.
10. Cai, W., and P. A. Schaffer. 1992. Herpes simplex virus type 1 ICP0 regulates expression of immediate-early, early, and late genes in productively infected cells. J. Virol. 66:2904-2915.
11. 134.5, a gene nonessential for growth in culture. Science 250:1262-1266.
12. 134.5 gene of herpes simplex virus. J. Virol. 68:8304-8311.
13. 134.5 gene of herpes simplex virus 1 precludes neuroblastoma cells from triggering total shutoff of protein synthesis characteristic of programed cell death in neuronal cells. Proc. Natl. Acad. Sci. USA 89:3266-3270.
14. Chou, J., and B. Roizman. 1990. The herpes simplex virus 1 gene of ICP34.5, which maps in inverted repeats, is conserved in several limited-passage isolates but not in strain 17syn+. J. Virol. 64:1014-1020.
15. Chou, J., and B. Roizman. 1986. The terminal a sequence of the herpes simplex virus genome contains the promoter of a gene located in the repeat sequences of the L component. J. Virol. 57:629-637.
16. DeLuca, N. A., and P. A. Schaffer. 1987. Activities of herpes simplex virus type 1 (HSV-1) ICP4 genes specifying nonsense peptides. Nucleic Acids Res. 15:4491-4511.
17. DeLuca, N. A., and P. A. Schaffer. 1988. Physical and functional domains of the herpes simplex virus transcriptional regulatory protein ICP4. J. Virol. 62: 732-743.
18. Dolan, A., E. McKie, A. R. MacLean, and D. J. McGeoch. 1992. Status of the ICP34.5 gene in herpes simplex virus type 1 strain 17. J. Gen. Virol. 73:971-973.
19. Fenwick, M. L. 1984. The effects of herpesviruses on cellular macromolecular synthesis, p. 359-390. In H. Fraenkel-Conrat and R. R. Wagner (ed.), Comprehensive virology, vol. 19. Plenum Press, New York, N.Y.
20. Frazier, D. P., D. Cox, E. M. Godshalk, and P. A. Schaffer. 1996. Identification of cis-acting sequences in the promoter of the herpes simplex virus type 1 latency-associated transcripts required for activation by nerve growth factor and sodium butyrate in PC12 cells. J. Virol. 70:7433-7444.
21. Greene, L. A., and A. S. Tischler. 1982. PC12 pheochromocytoma cultures in neurobiological research. Adv. Cell. Neurobiol. 3:373-414.
22. Harlow, E., and D. Lane (ed.). 1988. Antibodies, a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
23. Kunkel, T. A. 1985. Rapid and efficient site-specific mutagenesis without phenotypic selection. Proc. Natl. Acad. Sci. USA 82:488-492.
24. Laemmli, U. K. 1970. Cleavage of the structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-684.
25. Lagunoff, M., G. Randall, and B. Roizman. 1996. Phenotypic properties of herpes simplex virus 1 containing a derepressed open reading frame P gene. J. Virol. 70:1810-1817.
26. 134.5 gene and transcribed by an RNA 3′ coterminal with the unspliced latency-associated transcript. J. Virol. 68: 6021-6028.
27. Leib, D. A., C. L. Bogard, M. Kosz-Vnenchak, K. A. Hicks, D. M. Coen, D. M. Knipe, and P. A. Schaffer. 1989. A deletion mutant of the latency-associated transcript of herpes simplex virus type 1 reactivates from the latent state with reduced frequency. J. Virol. 63:2893-2900.
28. Leib, D. A., D. M. Coen, C. L. Bogard, K. A. Hicks, D. R. Yager, D. M. Knipe, K. L. Tyler, and P. A. Schaffer. 1989. Immediate-early regulatory gene mutants define different stages in the establishment and reactivation of herpes simplex virus latency. J. Virol. 63:759-768.
29. McGeoch, D. J., C. Cunningham, G. McIntyre, and A. Dolan. 1991. Comparative sequence analysis of the long repeat regions and adjoining parts of the long unique regions in the genomes of herpes simplex viruses types 1 and 2. J. Gen. Virol. 72:3057-3075.
30. + neurovirulence gene RL1 and its expression in a bacterial system. J. Gen. Virol. 75:733-741.
31. Perng, G.-C., H. Ghiasi, S. M. Slanina, A. B. Nesburn, and S. L. Wechsler. 1996. High-dose ocular infection with a herpes simplex virus type 1 ICP34.5 deletion mutant produces no corneal disease or neurovirulence yet results in wild-type levels of spontaneous reactivation. J. Virol. 70:2883-2893.
32. Perng, G.-C., R. L. Thompson, N. M. Sawtell, W. E. Taylor, S. M. Slanina, H. Ghiasi, R. Kaiwar, A. B. Nesburn, and S. L. Wechsler. 1995. An avirulent ICP34.5 deletion mutant of herpes simplex virus type 1 is capable of in vivo spontaneous reactivation. J. Virol. 69:3033-3041.
33. Ralph, W. M., Jr., M. S. Cabatingan, and P. A. Schaffer. 1994. Induction of HSV-1 immediate-early gene expression by a cellular activity expressed in Vero and NB41A3 cells following growth arrest-release. J. Virol. 68:6871-6882.
34. Randall, G., M. Lagunoff and B. Roizman. 1997. The product of ORF O located within the domain of herpes simplex virus type 1 genome transcribed during latent infection, binds to and inhibits binding of infected cell protein 4 to its cognate DNA site. Proc. Natl Acad. Sci. USA 94:1079-1084.
35. 134.5 gene and may account for the attenuation of the mutant virus. J. Virol. 71:7750-7757.
36. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent endpoints. Am. J. Hyg. 27:493-497.
37. Robertson, L. M., A. R. MacLean, and S. M. Brown. 1992. Peripheral replication and latency reactivation kinetics of the non-neurovirulent herpes simplex virus type 1 variant 1716. J. Gen. Virol. 73:967-970.
38. Sacks, W. R., C. C. Greene, D. P. Aschman, and P. A. Schaffer. 1985. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol. 55: 796-805.
39. Sambrook, J., E. F. Fritsch, and T. Maniatis. 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
40. Sandri-Goldin, R. M., M. Levine, and J. C. Glorioso. 1981. Method for introduction of mutations in physically defined regions of the herpes simplex virus genome. J. Virol. 38:41-49.
41. Schaffer, P. A., V. C. Carter, and M. C. Timbury. 1978. Collaborative complementation study of temperature-sensitive mutants of herpes simplex virus types 1 and 2. Virology 27:490-504.
42. Seed, B., and J. Y. Sheen. 1988. A simple phase-extraction assay for chlorampheniol acetyltransferase activity. Gene 67:271-277.
43. Showalter, S. D., M. Zweig, and B. Hampar. 1981. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP4. Infect. Immun. 34:684-692.
44. Southern, E. M. 1975. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J. Mol. Biol. 98:503-517.
45. Spivack, J. G., M. U. Fareed, T. Valyi-Nagy, T. C. Nash, J. S. O'Keefe, R. M. Gesser, E. A. McKie, A. R. MacLean, N. W. Fraser, and S. M. Brown. 1995. Replication, establishment of latent infection, expression of the latency-associated transcripts and explant reactivation of herpes simplex virus type 1 γ34.5 mutants in a mouse eye model. J. Gen. Virol. 76:321-332.
46. Taha, M. Y., G. B. Clements, and S. M. Brown. 1989. The herpes simplex virus type 2 (HG52) variant JH2604 has a 1488 bp deletion which eliminates neurovirulence in mice. J. Gen. Virol. 70:3072-3078.
47. L between 0 to 0.02 and 0.81 and 0.83 map units is non-neurovirulent for mice. J. Gen. Virol. 70:705-716.
48. + γ34.5 deletion mutant 1716 is avirulent in SCID mice. J. Gen. Virol. 75:2059-2063.
49. 134.5 deletion mutants in rodent models. J. Clin. Invest. 91: 2837-2843.
50. Yeh, L., and P. A. Schaffer. 1993. A novel class of transcripts expressed with late kinetics in the absence of ICP4 spans the junction between the long and short segments of the herpes simplex virus type 1 genome. J. Virol. 67:7373-7382.